Skip to main content
Erschienen in: Virchows Archiv 4/2006

01.10.2006 | Original Article

Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis—a paradoxical observation?

verfasst von: Torsten Hansen, C. James Kirkpatrick, Christian Walter, Martin Kunkel

Erschienen in: Virchows Archiv | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

Erosion of the bone is a common problem in patients suffering from infected osteoradionecrosis (IORN) or bisphosphonate-associated osteonecrosis (BON). Besides inflammatory mechanisms and infectious agents, osteoclasts were recently suggested to be specifically involved in the osteolytic mechanisms. We therefore investigated the immunohistochemical labeling of the cysteine proteinase cathepsin K, which plays a central role in osteoclast-mediated bone resorption, in tissue specimens of patients with BON (n=9; four male, five female; mean age=69.2 years) and IORN (n=10; nine male, one female; mean age=60.5 years), and compared the results with control specimens (n=8; six male, two female; mean age=60 years). In all cases, osteoclasts were the predominant cell type expressing cathepsin K. For semiquantitative analysis, we therefore defined osteoclasts as multinuclear giant cells attached to the bone and expressing cathepsin K. Significantly higher numbers of osteoclasts were found for both types of osteonecrosis when compared with the control group (BON+IORN vs controls: P=0.0000036). Within the pathological lesions, IORN cases exhibited significantly less osteoclasts than BON (P=0.00097). Our study verified increased numbers of osteoclasts in patients suffering from BON and IORN. Although it is known that bisphosphonates (and to a lesser extent, irradiation, too) decrease osteoclast function, these findings suggest a critical involvement of osteoclasts in the mechanisms of bone destruction in the respective lesions.
Literatur
1.
Zurück zum Zitat Abu-Id MH, Acil Y, Gottschalk J, Kreusch T (2006) Bisphosphonate-associated osteonecrosis of the jaw. Mund Kiefer Gesichtschir 10:72–81CrossRef Abu-Id MH, Acil Y, Gottschalk J, Kreusch T (2006) Bisphosphonate-associated osteonecrosis of the jaw. Mund Kiefer Gesichtschir 10:72–81CrossRef
2.
Zurück zum Zitat Aitasalo K (1986) Bone tissue response to irradiation and treatment model of mandibular irradiation injury. Acta Otolaryngol Suppl 428:1–54PubMed Aitasalo K (1986) Bone tissue response to irradiation and treatment model of mandibular irradiation injury. Acta Otolaryngol Suppl 428:1–54PubMed
3.
Zurück zum Zitat Altundal H, Güvener Ö (2004) The effect of alendronate on resorption of the alveolar bone following tooth extraction. Int J Oral Maxillofac Surg 33:286–293PubMedCrossRef Altundal H, Güvener Ö (2004) The effect of alendronate on resorption of the alveolar bone following tooth extraction. Int J Oral Maxillofac Surg 33:286–293PubMedCrossRef
4.
Zurück zum Zitat Andrews N, Griffiths C (2001) Dental complications of head and neck radiotherapy: part 1. Aust Dent J 46:88–94PubMed Andrews N, Griffiths C (2001) Dental complications of head and neck radiotherapy: part 1. Aust Dent J 46:88–94PubMed
5.
Zurück zum Zitat Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM, Silvestre FJ, Scully C (2005) Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 34:120–123PubMedCrossRef Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM, Silvestre FJ, Scully C (2005) Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 34:120–123PubMedCrossRef
6.
Zurück zum Zitat Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 34:8580–8587CrossRef Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 34:8580–8587CrossRef
7.
Zurück zum Zitat Curi MM, Dib LL, Kowalski LP, Landman G, Mangini C (2000) Opportunistic actinomycosis of the jaws in patients affected by head and neck cancer: incidence and clinical significance. Oral Oncol 36:294–299PubMedCrossRef Curi MM, Dib LL, Kowalski LP, Landman G, Mangini C (2000) Opportunistic actinomycosis of the jaws in patients affected by head and neck cancer: incidence and clinical significance. Oral Oncol 36:294–299PubMedCrossRef
8.
Zurück zum Zitat Garant PR (1976) Light and electron microscopic observations of osteoclastic alveolar bone resorption in rats monoinfected with Actinomyces naeslundii. J Periodontol 47:717–723PubMed Garant PR (1976) Light and electron microscopic observations of osteoclastic alveolar bone resorption in rats monoinfected with Actinomyces naeslundii. J Periodontol 47:717–723PubMed
9.
Zurück zum Zitat Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Ávilla-Campos MJ, Cunha FQ, Silva JS (2006) Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 21:12–20PubMedCrossRef Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Ávilla-Campos MJ, Cunha FQ, Silva JS (2006) Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 21:12–20PubMedCrossRef
10.
Zurück zum Zitat Glanzmann C, Grätz KW (1995) Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiother Oncol 36:94–100PubMedCrossRef Glanzmann C, Grätz KW (1995) Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiother Oncol 36:94–100PubMedCrossRef
11.
Zurück zum Zitat Hansen T, Otto M, Gaumann A, Eckardt A, Petrow PK, Delank KS, Kirkpatrick CJ, Kriegsmann J (2001) Cathepsin K in aseptic hip prosthesis loosening: expression in osteoclasts without polyethylene wear particles. J Rheumatol 28:1615–1619PubMed Hansen T, Otto M, Gaumann A, Eckardt A, Petrow PK, Delank KS, Kirkpatrick CJ, Kriegsmann J (2001) Cathepsin K in aseptic hip prosthesis loosening: expression in osteoclasts without polyethylene wear particles. J Rheumatol 28:1615–1619PubMed
12.
Zurück zum Zitat Hansen T, Unger RE, Gaumann A, Hundorf I, Maurer J, Kirkpatrick CJ, Kriegsmann J (2001) Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma. Mod Pathol 14:1226–1231PubMedCrossRef Hansen T, Unger RE, Gaumann A, Hundorf I, Maurer J, Kirkpatrick CJ, Kriegsmann J (2001) Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma. Mod Pathol 14:1226–1231PubMedCrossRef
13.
Zurück zum Zitat Hansen T, Kunkel M, Kirkpatrick CJ, Weber A (2006) Actinomyces in infected osteoradionecrosis—underestimated? Hum Pathol 37:61–67PubMedCrossRef Hansen T, Kunkel M, Kirkpatrick CJ, Weber A (2006) Actinomyces in infected osteoradionecrosis—underestimated? Hum Pathol 37:61–67PubMedCrossRef
14.
Zurück zum Zitat Hansen T, Kunkel M, Weber A, Kirkpatrick CJ (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates—histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155–160PubMedCrossRef Hansen T, Kunkel M, Weber A, Kirkpatrick CJ (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates—histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155–160PubMedCrossRef
15.
Zurück zum Zitat Happonen RP, Viander M, Pelliniemi L, Aitasalo K (1983) Actinomyces israelii in osteoradionecrosis of the jaws. Oral Surg Oral Med Oral Pathol 55:580–588PubMedCrossRef Happonen RP, Viander M, Pelliniemi L, Aitasalo K (1983) Actinomyces israelii in osteoradionecrosis of the jaws. Oral Surg Oral Med Oral Pathol 55:580–588PubMedCrossRef
16.
Zurück zum Zitat Henderson B, Nair SP, Ward JM, Wilson M (2003) Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 57:29–55PubMedCrossRef Henderson B, Nair SP, Ward JM, Wilson M (2003) Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 57:29–55PubMedCrossRef
17.
Zurück zum Zitat Kataoka M, Torisu T, Tsumura H, Hirayama T, Fujikawa Y (2000) Role of multinuclear cells in granulation tissue in osteomyelitis. Acta Orthop Scand 71:414–418PubMedCrossRef Kataoka M, Torisu T, Tsumura H, Hirayama T, Fujikawa Y (2000) Role of multinuclear cells in granulation tissue in osteomyelitis. Acta Orthop Scand 71:414–418PubMedCrossRef
18.
Zurück zum Zitat Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, Bilbe G (1997) Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81–86PubMedCrossRef Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, Bilbe G (1997) Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81–86PubMedCrossRef
19.
Zurück zum Zitat Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O (2004) Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117:440–441PubMedCrossRef Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O (2004) Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 117:440–441PubMedCrossRef
20.
Zurück zum Zitat Mann HB, Whitney DR (1947) On a test whether one or two random variables is stochastically larger than the other. Ann Math Stat 18:50 Mann HB, Whitney DR (1947) On a test whether one or two random variables is stochastically larger than the other. Ann Math Stat 18:50
21.
Zurück zum Zitat Marx RE (2003) Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1118PubMedCrossRef Marx RE (2003) Pamidronate (Aredia) and Zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1118PubMedCrossRef
22.
Zurück zum Zitat Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575PubMedCrossRef Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575PubMedCrossRef
23.
Zurück zum Zitat Millett DT, Chapple IL, Hirschmann PN, Corrigan AM (1990) Septic osteoradionecrosis of the mandible associated with pathological fracture: report of two cases. Clin Radiol 41:408–410PubMedCrossRef Millett DT, Chapple IL, Hirschmann PN, Corrigan AM (1990) Septic osteoradionecrosis of the mandible associated with pathological fracture: report of two cases. Clin Radiol 41:408–410PubMedCrossRef
24.
Zurück zum Zitat Nishida E, Hara Y, Kaneko T, Ikedo Y, Ukai T, Kato I (2001) Bone resorption and local interleukin-1α and interleukin-1β synthesis induced by Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res 36:1–8PubMedCrossRef Nishida E, Hara Y, Kaneko T, Ikedo Y, Ukai T, Kato I (2001) Bone resorption and local interleukin-1α and interleukin-1β synthesis induced by Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res 36:1–8PubMedCrossRef
25.
Zurück zum Zitat Reszka AA, Halasy-Nagy J, Rodan GA (2001) Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthesis pathway in a keratinocyte model for esophageal irritation. Mol Pharmacol 59:193–202PubMed Reszka AA, Halasy-Nagy J, Rodan GA (2001) Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthesis pathway in a keratinocyte model for esophageal irritation. Mol Pharmacol 59:193–202PubMed
26.
Zurück zum Zitat Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961–2978PubMedCrossRef Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961–2978PubMedCrossRef
28.
Zurück zum Zitat Ruggiero S, Mehrotra B, Rosenberg T, Engroff S (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527–534PubMedCrossRef Ruggiero S, Mehrotra B, Rosenberg T, Engroff S (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527–534PubMedCrossRef
29.
Zurück zum Zitat Scheven BA, Wassenaar AM, Kawiralang-de Haas EW, Nijweide PJ (1987) Direct and indirect radiation effects on osteoclast formation in vitro. Bone Miner 2:291–300PubMed Scheven BA, Wassenaar AM, Kawiralang-de Haas EW, Nijweide PJ (1987) Direct and indirect radiation effects on osteoclast formation in vitro. Bone Miner 2:291–300PubMed
30.
Zurück zum Zitat Støre G, Boysen M (2000) Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol 25:378–384PubMedCrossRef Støre G, Boysen M (2000) Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol 25:378–384PubMedCrossRef
31.
Zurück zum Zitat Støre G, Eribe ERK, Olsen I (2005) DNA–DNA hybridization demonstrates multiple bacteria in osteoradionecrosis. Int J Oral Maxillofac Surg 34:193–196PubMedCrossRef Støre G, Eribe ERK, Olsen I (2005) DNA–DNA hybridization demonstrates multiple bacteria in osteoradionecrosis. Int J Oral Maxillofac Surg 34:193–196PubMedCrossRef
32.
Zurück zum Zitat Thiel HJ (1989) The osteoradionecrosis. Part I: etiology, pathogenesis, clinic, and risk factors. Radiobiol Radiother 30:397–413 Thiel HJ (1989) The osteoradionecrosis. Part I: etiology, pathogenesis, clinic, and risk factors. Radiobiol Radiother 30:397–413
33.
Zurück zum Zitat Thompson K, Dunford JE, Ebetino FH, Rogers MJ (2002) Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase. Biochem Biophys Res Commun 290:869–873PubMedCrossRef Thompson K, Dunford JE, Ebetino FH, Rogers MJ (2002) Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase. Biochem Biophys Res Commun 290:869–873PubMedCrossRef
34.
Zurück zum Zitat Väänänen K (2005) Mechanism of osteoclast mediated bone resorption—rationale for the design of new therapeutics. Adv Drug Deliv Rev 57:959–971PubMedCrossRef Väänänen K (2005) Mechanism of osteoclast mediated bone resorption—rationale for the design of new therapeutics. Adv Drug Deliv Rev 57:959–971PubMedCrossRef
35.
Zurück zum Zitat Van Driessche K, van Ranst D, van Offel J, Stevens WJ, De Schepper A, van Marck E, De Clerck LS (2003) Actinomycosis as a rare cause of vertebral osteolysis. Acta Clin Belg 58:296–298PubMed Van Driessche K, van Ranst D, van Offel J, Stevens WJ, De Schepper A, van Marck E, De Clerck LS (2003) Actinomycosis as a rare cause of vertebral osteolysis. Acta Clin Belg 58:296–298PubMed
36.
Zurück zum Zitat Yamaza T, Goto T, Kamiya T, Kobayashi Y, Sakai H, Tanaka T (1998) Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23:499–509PubMedCrossRef Yamaza T, Goto T, Kamiya T, Kobayashi Y, Sakai H, Tanaka T (1998) Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23:499–509PubMedCrossRef
37.
Zurück zum Zitat Yamaza T, Tsuji Y, Goto T, Kido MA, Nishijima K, Moroi R, Akamine A, Tanaka T (2001) Comparison in localization between cystatin C and cathepsin K in osteoclasts and other cells in mouse tibia epiphysis by immunolight and immunoelectron microscopy. Bone 29:42–53PubMedCrossRef Yamaza T, Tsuji Y, Goto T, Kido MA, Nishijima K, Moroi R, Akamine A, Tanaka T (2001) Comparison in localization between cystatin C and cathepsin K in osteoclasts and other cells in mouse tibia epiphysis by immunolight and immunoelectron microscopy. Bone 29:42–53PubMedCrossRef
Metadaten
Titel
Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis—a paradoxical observation?
verfasst von
Torsten Hansen
C. James Kirkpatrick
Christian Walter
Martin Kunkel
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 4/2006
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-006-0261-y

Weitere Artikel der Ausgabe 4/2006

Virchows Archiv 4/2006 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …